Efforts by the medical community to designate severe IgA nephropathy as a rare disease to improve patient access to treatment ...

GC Biopharma said Friday that it will submit later in the day an investigational new drug (IND) application to the Ministry ...

Kolon TissueGene's osteoarthritis cell and gene therapy candidate TG-C (formerly Invossa) has failed to meet its co-primary ...

HLB, a Korean cancer drug developer, said Friday that it has completed a late-cycle meeting with the U.S. FDA as part of the ...

It was 2 a.m., and a patient's family member heard the same answer for the third time in a regional emergency ...

Oscotec Inc. has completed the inheritance process following the death of its founder and former Chairman Kim Jung-geun, with ...

Hanmi Pharmaceutical said Friday it has developed a proprietary AI platform capable of predicting the pharmacological ...

AriBio said Wednesday that results from the global phase 3 trial of its oral Alzheimer’s disease candidate AR1001 will be ...

Researchers at Seoul National University Hospital (SNUH) have uncovered how the EZH1 Q571R mutation, a genetic alteration ...

Korea will launch a government-led initiative in the second half of this year to establish evidence-based standards for ...

Samsung Biologics said July 23 that it recorded revenue of 1.32 trillion won ($893.1 million) and operating profit of 586.4 ...

Coffee, one of the world's most popular beverages, has long been surrounded by a variety of health claims.One of the most ...